What has changed for patients with newly diagnosed GBM over the last decade? An institutional review of treatment modalities and outcome in 339 patients

Hans Christoph Bock, Jose Maria Hinz, Angelika Gutenberg, Timo Behm, Veit Rohde & Alf Giese
Objective: Up-to-date treatment options for patients with newly diagnosed glioblastoma (GBM) have always been established by randomized clinical trials in which the treated patient population is highly selected and homogeneous. Postoperative concomitant radiochemotherapy followed by temozolomide monotherapy[for full text, please go to the a.m. URL]